Atlas Trials

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

Clinical trial NCT01167335 · WITHDRAWN

Trial details

NCT number
NCT01167335
Sponsor
Novartis
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Partial Onset Seizures
Start date
2010-08-01
Primary completion
2010-11-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.